Caroline Rufo


Merck Ventures
Gustav Mahlerplein 102
Toyo lto Building, 20th Floor
1082 MA Amsterdam
The Netherlands

Caroline Rufo, PhD, joined the Healthcare Team as an analyst in April 2017. Previously, Caroline was a Postdoctoral Associate at Yale University (USA) in the Department of Molecular Biophysics and Biochemistry where she performed research focusing on the influence of the Rho/ROCK signaling pathway on cancer drugs. Caroline received her PhD in Chemistry from Syracuse University (USA) and her research studying the self-assembly of small peptides to create catalysts was published in Nature Chemistry. Caroline is based in Amsterdam.

Portfolio Company

more about
Akili